Gene Symbol | Gene ID | Gene Info |
---|---|---|
Smad1
|
ENSMUSG00000031681.8 | SMAD family member 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr8_79385060_79385222 | Smad1 | 14377 | 0.171857 | 0.32 | 1.4e-02 | Click! |
chr8_79355856_79356454 | Smad1 | 523 | 0.784806 | 0.27 | 3.5e-02 | Click! |
chr8_79384289_79385053 | Smad1 | 14847 | 0.171121 | 0.23 | 7.9e-02 | Click! |
chr8_79382713_79382865 | Smad1 | 16729 | 0.168140 | 0.22 | 9.3e-02 | Click! |
chr8_79350421_79350572 | Smad1 | 445 | 0.826833 | 0.20 | 1.3e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_57320946_57324000 | 14.45 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr11_96347886_96350398 | 13.57 |
Hoxb3os |
homeobox B3 and homeobox B2, opposite strand |
1219 |
0.21 |
chr1_168426195_168428871 | 13.22 |
Pbx1 |
pre B cell leukemia homeobox 1 |
3971 |
0.3 |
chr14_67236008_67239452 | 13.13 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr12_91683421_91686419 | 13.03 |
Gm16876 |
predicted gene, 16876 |
255 |
0.86 |
chr11_103013495_103014790 | 12.80 |
Dcakd |
dephospho-CoA kinase domain containing |
3026 |
0.16 |
chr19_45230983_45235468 | 12.13 |
Lbx1 |
ladybird homeobox 1 |
2587 |
0.27 |
chr17_12636042_12637507 | 11.64 |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
15934 |
0.17 |
chr9_41326803_41329121 | 11.00 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
676 |
0.69 |
chr10_107483887_107486076 | 10.04 |
Myf5 |
myogenic factor 5 |
1153 |
0.46 |
chr2_74745819_74748448 | 9.80 |
Hoxd3 |
homeobox D3 |
1411 |
0.17 |
chr2_9882196_9886301 | 9.76 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr9_71892666_71893902 | 9.50 |
Tcf12 |
transcription factor 12 |
2701 |
0.17 |
chr1_163308490_163310681 | 9.45 |
Gm37644 |
predicted gene, 37644 |
518 |
0.77 |
chr3_87949543_87950464 | 9.41 |
Crabp2 |
cellular retinoic acid binding protein II |
1337 |
0.25 |
chr5_75148315_75152589 | 9.20 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr14_52310870_52313267 | 8.78 |
Sall2 |
spalt like transcription factor 2 |
4255 |
0.1 |
chr5_119673827_119675890 | 8.70 |
Tbx3 |
T-box 3 |
587 |
0.67 |
chr13_116707579_116709380 | 8.70 |
Gm47914 |
predicted gene, 47914 |
30774 |
0.17 |
chr2_146834060_146838027 | 8.57 |
Gm14114 |
predicted gene 14114 |
3689 |
0.27 |
chr1_24195123_24196359 | 8.54 |
Col9a1 |
collagen, type IX, alpha 1 |
554 |
0.82 |
chr10_120851641_120852034 | 8.33 |
Msrb3 |
methionine sulfoxide reductase B3 |
1369 |
0.35 |
chr10_125785515_125788000 | 8.31 |
Lrig3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
179411 |
0.03 |
chr2_33639069_33641423 | 8.24 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
234 |
0.85 |
chr8_57326741_57329467 | 7.87 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr13_72629730_72632045 | 7.86 |
Irx2 |
Iroquois homeobox 2 |
1062 |
0.51 |
chr2_52038470_52039720 | 7.77 |
Tnfaip6 |
tumor necrosis factor alpha induced protein 6 |
1086 |
0.54 |
chr1_162217585_162219370 | 7.74 |
Dnm3os |
dynamin 3, opposite strand |
601 |
0.46 |
chr13_15466077_15468087 | 7.34 |
Gli3 |
GLI-Kruppel family member GLI3 |
3102 |
0.22 |
chr1_78193153_78194695 | 7.32 |
Pax3 |
paired box 3 |
2914 |
0.3 |
chr13_55827549_55829422 | 7.32 |
Gm47071 |
predicted gene, 47071 |
2235 |
0.21 |
chr6_23247289_23250418 | 7.30 |
Fezf1 |
Fez family zinc finger 1 |
491 |
0.76 |
chr18_75384437_75388058 | 7.20 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr15_73021529_73022598 | 7.20 |
Trappc9 |
trafficking protein particle complex 9 |
33747 |
0.18 |
chr9_107489458_107490875 | 7.09 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
15438 |
0.08 |
chrX_143825863_143827628 | 7.03 |
Capn6 |
calpain 6 |
587 |
0.46 |
chr11_18873955_18876215 | 7.03 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
776 |
0.61 |
chr13_63557270_63560459 | 6.91 |
Ptch1 |
patched 1 |
4951 |
0.16 |
chr2_74725879_74728683 | 6.86 |
Hoxd4 |
homeobox D4 |
207 |
0.67 |
chr12_53061586_53062872 | 6.83 |
n-R5s58 |
nuclear encoded rRNA 5S 58 |
15403 |
0.29 |
chr5_37826544_37829286 | 6.70 |
Msx1 |
msh homeobox 1 |
3332 |
0.25 |
chr3_34662808_34665047 | 6.68 |
Gm42693 |
predicted gene 42693 |
362 |
0.74 |
chr15_98001331_98003530 | 6.63 |
Col2a1 |
collagen, type II, alpha 1 |
543 |
0.74 |
chr9_55543267_55546069 | 6.47 |
Isl2 |
insulin related protein 2 (islet 2) |
2332 |
0.22 |
chr5_122105936_122106110 | 6.45 |
Myl2 |
myosin, light polypeptide 2, regulatory, cardiac, slow |
2110 |
0.23 |
chr10_42581935_42584872 | 6.42 |
Nr2e1 |
nuclear receptor subfamily 2, group E, member 1 |
229 |
0.69 |
chr7_96645272_96646140 | 6.40 |
Tenm4 |
teneurin transmembrane protein 4 |
1534 |
0.45 |
chr13_49399313_49399700 | 6.35 |
Bicd2 |
BICD cargo adaptor 2 |
16417 |
0.17 |
chr6_121412448_121413667 | 6.32 |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
54092 |
0.1 |
chr11_84520959_84524590 | 6.29 |
Lhx1 |
LIM homeobox protein 1 |
63 |
0.97 |
chr8_121118797_121121438 | 6.28 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr3_99255907_99257438 | 6.20 |
Tbx15 |
T-box 15 |
2912 |
0.22 |
chr7_142662290_142664788 | 6.05 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr11_96202439_96204563 | 6.05 |
Hoxb13 |
homeobox B13 |
9185 |
0.1 |
chr8_57319308_57320679 | 6.01 |
Hand2os1 |
Hand2, opposite strand 1 |
63 |
0.94 |
chr9_58128949_58130350 | 5.94 |
Stra6 |
stimulated by retinoic acid gene 6 |
148 |
0.93 |
chr1_14308374_14310407 | 5.94 |
Eya1 |
EYA transcriptional coactivator and phosphatase 1 |
446 |
0.88 |
chr2_30846598_30847361 | 5.92 |
Prrx2 |
paired related homeobox 2 |
1535 |
0.29 |
chr8_57324709_57326732 | 5.91 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr1_190902701_190903139 | 5.90 |
Rps6kc1 |
ribosomal protein S6 kinase polypeptide 1 |
3203 |
0.22 |
chr9_114560970_114561936 | 5.87 |
Trim71 |
tripartite motif-containing 71 |
2916 |
0.23 |
chr13_53471272_53471968 | 5.85 |
Msx2 |
msh homeobox 2 |
1454 |
0.42 |
chr3_87150105_87151405 | 5.78 |
Gm37855 |
predicted gene, 37855 |
6938 |
0.18 |
chr8_121088119_121090419 | 5.76 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr12_33345030_33346384 | 5.76 |
Atxn7l1 |
ataxin 7-like 1 |
402 |
0.85 |
chr7_96643662_96644951 | 5.70 |
Tenm4 |
teneurin transmembrane protein 4 |
134 |
0.97 |
chr18_37720288_37722950 | 5.69 |
Pcdhgb4 |
protocadherin gamma subfamily B, 4 |
1236 |
0.14 |
chr3_107594877_107596190 | 5.68 |
Alx3 |
aristaless-like homeobox 3 |
502 |
0.74 |
chr11_69399334_69402458 | 5.66 |
Kdm6bos |
KDM1 lysine (K)-specific demethylase 6B, opposite strand |
617 |
0.47 |
chr11_85836730_85838643 | 5.65 |
Tbx2 |
T-box 2 |
5135 |
0.14 |
chr3_129216664_129219042 | 5.61 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
3578 |
0.2 |
chr5_67227248_67228871 | 5.60 |
Tmem33 |
transmembrane protein 33 |
32506 |
0.14 |
chr7_49634786_49637154 | 5.59 |
Dbx1 |
developing brain homeobox 1 |
879 |
0.68 |
chr5_92808964_92810706 | 5.55 |
Shroom3 |
shroom family member 3 |
365 |
0.88 |
chr13_73262153_73264451 | 5.54 |
Irx4 |
Iroquois homeobox 4 |
2805 |
0.22 |
chr12_117150370_117151613 | 5.53 |
Gm10421 |
predicted gene 10421 |
224 |
0.96 |
chr2_9880695_9881908 | 5.52 |
4930412O13Rik |
RIKEN cDNA 4930412O13 gene |
49 |
0.95 |
chr12_76071969_76072878 | 5.51 |
Syne2 |
spectrin repeat containing, nuclear envelope 2 |
407 |
0.88 |
chr10_70598201_70600143 | 5.50 |
Phyhipl |
phytanoyl-CoA hydroxylase interacting protein-like |
90 |
0.98 |
chr3_55782570_55784448 | 5.49 |
Nbea |
neurobeachin |
19 |
0.96 |
chr5_37818003_37820431 | 5.46 |
Msx1 |
msh homeobox 1 |
5365 |
0.21 |
chr13_53465314_53466718 | 5.41 |
Msx2 |
msh homeobox 2 |
7058 |
0.2 |
chr2_74713881_74716227 | 5.41 |
Hoxd3os1 |
homeobox D3, opposite strand 1 |
942 |
0.23 |
chr1_162219788_162220533 | 5.40 |
Dnm3os |
dynamin 3, opposite strand |
292 |
0.87 |
chr14_28508967_28511864 | 5.39 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr11_101892225_101894406 | 5.39 |
Meox1 |
mesenchyme homeobox 1 |
1059 |
0.4 |
chr2_45103994_45106973 | 5.34 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
4593 |
0.23 |
chr18_54827745_54829243 | 5.33 |
Gm33732 |
predicted gene, 33732 |
4705 |
0.2 |
chr13_55835316_55837389 | 5.32 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
160 |
0.62 |
chr11_103264207_103265876 | 5.30 |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
2431 |
0.19 |
chr2_18039562_18041859 | 5.30 |
A930004D18Rik |
RIKEN cDNA A930004D18 gene |
2973 |
0.14 |
chr6_52199825_52201748 | 5.29 |
Hoxaas3 |
Hoxa cluster antisense RNA 3 |
338 |
0.63 |
chr17_93198991_93201483 | 5.29 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr5_37241461_37244349 | 5.29 |
Crmp1 |
collapsin response mediator protein 1 |
171 |
0.95 |
chr18_55546722_55548385 | 5.28 |
Gm37337 |
predicted gene, 37337 |
30439 |
0.24 |
chr1_166126774_166128045 | 5.23 |
Dusp27 |
dual specificity phosphatase 27 (putative) |
487 |
0.76 |
chr11_85838795_85841602 | 5.23 |
Tbx2 |
T-box 2 |
7647 |
0.13 |
chr7_30314557_30315674 | 5.18 |
Syne4 |
spectrin repeat containing, nuclear envelope family member 4 |
35 |
0.92 |
chr4_154635108_154637998 | 5.17 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr1_163358681_163359585 | 5.15 |
Gm24940 |
predicted gene, 24940 |
43150 |
0.12 |
chr17_75177945_75179637 | 5.14 |
Ltbp1 |
latent transforming growth factor beta binding protein 1 |
19 |
0.98 |
chr1_170109295_170110836 | 5.13 |
Ddr2 |
discoidin domain receptor family, member 2 |
436 |
0.82 |
chr18_60646910_60648302 | 5.12 |
Synpo |
synaptopodin |
666 |
0.69 |
chr11_61485409_61486536 | 5.07 |
Mfap4 |
microfibrillar-associated protein 4 |
456 |
0.71 |
chr4_114911575_114914085 | 5.06 |
Foxd2os |
forkhead box D2, opposite strand |
3573 |
0.16 |
chr7_38074216_38075175 | 5.04 |
Gm30684 |
predicted gene, 30684 |
12995 |
0.15 |
chr1_78195176_78196209 | 5.02 |
Pax3 |
paired box 3 |
1146 |
0.55 |
chr8_92364963_92367136 | 5.00 |
Irx5 |
Iroquois homeobox 5 |
8300 |
0.18 |
chr1_131232374_131233673 | 4.98 |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
552 |
0.67 |
chr9_24769617_24771807 | 4.96 |
Tbx20 |
T-box 20 |
962 |
0.56 |
chr5_101663868_101665354 | 4.96 |
Nkx6-1 |
NK6 homeobox 1 |
385 |
0.86 |
chr12_57538344_57540173 | 4.95 |
Foxa1 |
forkhead box A1 |
6863 |
0.16 |
chr14_25556458_25556785 | 4.92 |
Mir3075 |
microRNA 3075 |
22182 |
0.16 |
chr11_21992790_21995427 | 4.92 |
Otx1 |
orthodenticle homeobox 1 |
7507 |
0.25 |
chr7_139581551_139582997 | 4.91 |
Nkx6-2 |
NK6 homeobox 2 |
516 |
0.79 |
chr6_51169545_51171295 | 4.90 |
Mir148a |
microRNA 148a |
99490 |
0.07 |
chr9_72779927_72780473 | 4.90 |
Gm27204 |
predicted gene 27204 |
3975 |
0.14 |
chr2_157974620_157975884 | 4.90 |
Tti1 |
TELO2 interacting protein 1 |
31960 |
0.14 |
chr13_78189592_78191761 | 4.89 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
233 |
0.9 |
chr4_22479026_22480517 | 4.89 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
8595 |
0.17 |
chr11_69903386_69904806 | 4.89 |
Neurl4 |
neuralized E3 ubiquitin protein ligase 4 |
61 |
0.9 |
chr3_101599794_101602594 | 4.88 |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
3490 |
0.21 |
chr2_31638722_31641540 | 4.85 |
Prdm12 |
PR domain containing 12 |
94 |
0.84 |
chr7_30633440_30635827 | 4.84 |
Etv2 |
ets variant 2 |
1219 |
0.2 |
chr2_166154197_166155631 | 4.80 |
Sulf2 |
sulfatase 2 |
108 |
0.96 |
chr13_53284900_53286176 | 4.80 |
Ror2 |
receptor tyrosine kinase-like orphan receptor 2 |
11 |
0.99 |
chr17_81737002_81738450 | 4.78 |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
651 |
0.81 |
chr10_97566192_97567945 | 4.76 |
Lum |
lumican |
1940 |
0.32 |
chr11_85829139_85831432 | 4.76 |
2610027K06Rik |
RIKEN cDNA 2610027K06 gene |
1924 |
0.21 |
chr13_60479224_60481361 | 4.75 |
Gm48500 |
predicted gene, 48500 |
1006 |
0.51 |
chr5_128603772_128604461 | 4.75 |
Fzd10 |
frizzled class receptor 10 |
3272 |
0.19 |
chrX_11798219_11798370 | 4.72 |
Gm26314 |
predicted gene, 26314 |
52190 |
0.14 |
chr17_85686512_85689764 | 4.72 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr2_33713186_33713886 | 4.71 |
9430024E24Rik |
RIKEN cDNA 9430024E24 gene |
5363 |
0.21 |
chr6_56018257_56018963 | 4.69 |
Ppp1r17 |
protein phosphatase 1, regulatory subunit 17 |
1113 |
0.64 |
chr8_107545084_107547731 | 4.68 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chr15_27786588_27788615 | 4.68 |
Trio |
triple functional domain (PTPRF interacting) |
1037 |
0.6 |
chr11_22006485_22009037 | 4.65 |
Otx1 |
orthodenticle homeobox 1 |
4864 |
0.28 |
chr16_31162846_31163196 | 4.65 |
Gm18237 |
predicted gene, 18237 |
5151 |
0.19 |
chr1_19209346_19210955 | 4.65 |
Tfap2b |
transcription factor AP-2 beta |
1190 |
0.5 |
chr8_57333046_57334560 | 4.64 |
Gm34030 |
predicted gene, 34030 |
584 |
0.59 |
chr5_37821115_37822599 | 4.64 |
Msx1 |
msh homeobox 1 |
2725 |
0.28 |
chr7_70347472_70349327 | 4.63 |
Gm44948 |
predicted gene 44948 |
703 |
0.54 |
chr11_19015600_19017063 | 4.61 |
Meis1 |
Meis homeobox 1 |
42 |
0.96 |
chr6_94695739_94697689 | 4.61 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
3423 |
0.29 |
chr16_92054225_92054415 | 4.60 |
Mrps6 |
mitochondrial ribosomal protein S6 |
3950 |
0.13 |
chr1_131230888_131231108 | 4.60 |
Rassf5 |
Ras association (RalGDS/AF-6) domain family member 5 |
2577 |
0.19 |
chr10_99267189_99269284 | 4.60 |
Gm48089 |
predicted gene, 48089 |
340 |
0.78 |
chr12_40132983_40134645 | 4.59 |
Scin |
scinderin |
369 |
0.86 |
chr18_80984086_80984990 | 4.59 |
Sall3 |
spalt like transcription factor 3 |
1998 |
0.23 |
chr3_31097203_31098928 | 4.59 |
Skil |
SKI-like |
1232 |
0.48 |
chr11_19009505_19011164 | 4.57 |
Gm16140 |
predicted gene 16140 |
1204 |
0.32 |
chr10_68278824_68280301 | 4.55 |
Arid5b |
AT rich interactive domain 5B (MRF1-like) |
822 |
0.67 |
chr3_34648572_34651394 | 4.54 |
Sox2 |
SRY (sex determining region Y)-box 2 |
422 |
0.73 |
chr11_18870055_18872175 | 4.54 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
1040 |
0.49 |
chr13_56251216_56252886 | 4.53 |
Neurog1 |
neurogenin 1 |
112 |
0.95 |
chr12_110187430_110189676 | 4.52 |
Gm34785 |
predicted gene, 34785 |
492 |
0.73 |
chr17_55999652_56000753 | 4.51 |
Stap2 |
signal transducing adaptor family member 2 |
1722 |
0.17 |
chr1_59484043_59485554 | 4.50 |
Fzd7 |
frizzled class receptor 7 |
2374 |
0.22 |
chr10_127268122_127269422 | 4.50 |
Dctn2 |
dynactin 2 |
2385 |
0.12 |
chr6_30737706_30740349 | 4.50 |
Mest |
mesoderm specific transcript |
972 |
0.4 |
chr12_117657998_117660727 | 4.49 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr5_106465135_106467300 | 4.48 |
Gm26872 |
predicted gene, 26872 |
4790 |
0.19 |
chr2_24607306_24608299 | 4.48 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
268 |
0.89 |
chr19_14890066_14891687 | 4.48 |
Gm5513 |
predicted pseudogene 5513 |
69890 |
0.14 |
chr5_100078881_100080078 | 4.47 |
Tmem150cos |
transmembrane protein 150C, opposite strand |
1517 |
0.32 |
chr10_19351991_19353468 | 4.45 |
Olig3 |
oligodendrocyte transcription factor 3 |
3804 |
0.28 |
chr3_99261050_99262399 | 4.45 |
Gm43120 |
predicted gene 43120 |
439 |
0.81 |
chr6_52309839_52312950 | 4.44 |
Evx1 |
even-skipped homeobox 1 |
2104 |
0.14 |
chr10_69785224_69786670 | 4.44 |
Ank3 |
ankyrin 3, epithelial |
422 |
0.91 |
chr2_115857285_115858726 | 4.41 |
Meis2 |
Meis homeobox 2 |
10862 |
0.3 |
chr15_7814562_7815925 | 4.40 |
Gdnf |
glial cell line derived neurotrophic factor |
4397 |
0.24 |
chr5_143000025_143001100 | 4.40 |
Rnf216 |
ring finger protein 216 |
16212 |
0.14 |
chr2_172549301_172551909 | 4.39 |
Tfap2c |
transcription factor AP-2, gamma |
48 |
0.98 |
chr1_72870179_72872445 | 4.38 |
Igfbp5 |
insulin-like growth factor binding protein 5 |
2963 |
0.29 |
chr2_31641562_31642591 | 4.38 |
Gm13425 |
predicted gene 13425 |
1487 |
0.23 |
chr1_163311555_163312976 | 4.37 |
Prrx1 |
paired related homeobox 1 |
1403 |
0.39 |
chr7_80746141_80746557 | 4.34 |
Iqgap1 |
IQ motif containing GTPase activating protein 1 |
2469 |
0.25 |
chr4_154422469_154423086 | 4.34 |
Prdm16 |
PR domain containing 16 |
74320 |
0.08 |
chr2_116068937_116070512 | 4.34 |
G630016G05Rik |
RIKEN cDNA G630016G05 gene |
1756 |
0.28 |
chr18_77564636_77565784 | 4.32 |
Rnf165 |
ring finger protein 165 |
49 |
0.98 |
chrX_105390628_105392456 | 4.31 |
5330434G04Rik |
RIKEN cDNA 5330434G04 gene |
212 |
0.93 |
chr16_91222072_91224159 | 4.29 |
Gm49614 |
predicted gene, 49614 |
189 |
0.9 |
chr3_131136488_131137676 | 4.29 |
Gm42449 |
predicted gene 42449 |
297 |
0.9 |
chr8_105520321_105521493 | 4.29 |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
2152 |
0.16 |
chr7_112684407_112685864 | 4.29 |
2310014F06Rik |
RIKEN cDNA 2310014F06 gene |
5054 |
0.18 |
chr3_66977838_66980287 | 4.27 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr7_25802106_25803222 | 4.26 |
Gm45226 |
predicted gene 45226 |
7511 |
0.08 |
chr7_18962222_18963745 | 4.26 |
Nanos2 |
nanos C2HC-type zinc finger 2 |
24417 |
0.07 |
chr11_33195808_33198485 | 4.26 |
Tlx3 |
T cell leukemia, homeobox 3 |
6443 |
0.15 |
chr11_4308350_4309311 | 4.25 |
Gm24803 |
predicted gene, 24803 |
15425 |
0.12 |
chr9_53974078_53975628 | 4.25 |
Elmod1 |
ELMO/CED-12 domain containing 1 |
212 |
0.95 |
chr5_37893335_37894648 | 4.24 |
Gm20052 |
predicted gene, 20052 |
52 |
0.98 |
chr10_57784547_57786586 | 4.23 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr11_42419852_42421693 | 4.22 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
507 |
0.88 |
chr10_69925300_69927130 | 4.22 |
Ank3 |
ankyrin 3, epithelial |
82 |
0.99 |
chr15_13172045_13174125 | 4.22 |
Cdh6 |
cadherin 6 |
590 |
0.84 |
chr3_34656299_34657721 | 4.21 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
974 |
0.4 |
chr11_85833878_85836704 | 4.19 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr17_25556052_25557244 | 4.19 |
Gm50026 |
predicted gene, 50026 |
4565 |
0.09 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 36.0 | GO:0003166 | bundle of His development(GO:0003166) |
7.9 | 23.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
7.1 | 14.3 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
6.4 | 19.1 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
6.2 | 18.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
6.1 | 18.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
6.0 | 23.9 | GO:0061205 | paramesonephric duct development(GO:0061205) |
6.0 | 23.8 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
5.8 | 23.3 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
5.7 | 17.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
5.6 | 11.2 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
5.5 | 16.5 | GO:0060594 | mammary gland specification(GO:0060594) |
4.9 | 14.8 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
4.9 | 19.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
4.5 | 13.4 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
4.5 | 8.9 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
4.3 | 13.0 | GO:0072092 | ureteric bud invasion(GO:0072092) |
4.2 | 12.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
4.1 | 45.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
4.1 | 4.1 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
4.0 | 8.1 | GO:0070384 | Harderian gland development(GO:0070384) |
4.0 | 8.0 | GO:0072275 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
4.0 | 16.0 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
3.9 | 11.6 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
3.8 | 11.5 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) |
3.7 | 11.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
3.7 | 3.7 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
3.6 | 14.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
3.6 | 3.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
3.6 | 10.8 | GO:0021557 | oculomotor nerve development(GO:0021557) |
3.6 | 25.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
3.5 | 3.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
3.5 | 10.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
3.4 | 17.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
3.4 | 10.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
3.4 | 3.4 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
3.3 | 10.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
3.2 | 3.2 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
3.1 | 9.4 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
3.1 | 12.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
3.1 | 6.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
3.1 | 15.6 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
3.1 | 12.4 | GO:0030035 | microspike assembly(GO:0030035) |
3.0 | 12.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
3.0 | 3.0 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.9 | 2.9 | GO:0060435 | bronchiole development(GO:0060435) |
2.9 | 8.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
2.8 | 8.5 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
2.8 | 59.4 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
2.8 | 11.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
2.8 | 5.5 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
2.8 | 2.8 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
2.7 | 10.9 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.7 | 10.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.7 | 2.7 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
2.7 | 5.3 | GO:0060513 | prostatic bud formation(GO:0060513) |
2.7 | 13.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
2.6 | 10.6 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
2.6 | 7.8 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
2.6 | 10.4 | GO:0060539 | diaphragm development(GO:0060539) |
2.6 | 12.9 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.5 | 7.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.5 | 5.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
2.5 | 7.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
2.5 | 4.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
2.4 | 2.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
2.3 | 11.7 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
2.3 | 7.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
2.3 | 2.3 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
2.3 | 9.2 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
2.3 | 16.0 | GO:0048664 | neuron fate determination(GO:0048664) |
2.3 | 4.6 | GO:0007403 | glial cell fate determination(GO:0007403) |
2.3 | 11.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
2.3 | 6.8 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.3 | 2.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
2.3 | 4.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.3 | 9.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
2.2 | 2.2 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
2.2 | 4.4 | GO:0014029 | neural crest formation(GO:0014029) |
2.2 | 4.4 | GO:0021550 | medulla oblongata development(GO:0021550) |
2.2 | 8.6 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
2.2 | 4.3 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
2.1 | 8.6 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
2.1 | 8.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
2.1 | 4.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.1 | 29.8 | GO:0003417 | growth plate cartilage development(GO:0003417) |
2.1 | 10.6 | GO:0003416 | endochondral bone growth(GO:0003416) |
2.1 | 2.1 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
2.1 | 6.3 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
2.1 | 8.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
2.1 | 6.2 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
2.1 | 8.3 | GO:0014028 | notochord formation(GO:0014028) |
2.1 | 6.2 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
2.1 | 6.2 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
2.1 | 8.2 | GO:0007412 | axon target recognition(GO:0007412) |
2.0 | 10.2 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
2.0 | 4.0 | GO:0001757 | somite specification(GO:0001757) |
2.0 | 6.1 | GO:0007494 | midgut development(GO:0007494) |
2.0 | 6.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
2.0 | 6.1 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
2.0 | 16.1 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
2.0 | 4.0 | GO:0003010 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
2.0 | 2.0 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
2.0 | 6.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
2.0 | 4.0 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.0 | 2.0 | GO:0060026 | convergent extension(GO:0060026) |
1.9 | 1.9 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
1.9 | 7.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.9 | 1.9 | GO:0048880 | sensory system development(GO:0048880) |
1.9 | 1.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.9 | 7.6 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.9 | 5.7 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.9 | 7.4 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
1.9 | 5.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.8 | 3.7 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
1.8 | 1.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.8 | 12.8 | GO:0043584 | nose development(GO:0043584) |
1.8 | 1.8 | GO:0060437 | lung growth(GO:0060437) |
1.8 | 7.3 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
1.8 | 8.9 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
1.8 | 1.8 | GO:0061055 | myotome development(GO:0061055) |
1.8 | 3.6 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.8 | 3.6 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.8 | 12.4 | GO:0071493 | cellular response to UV-B(GO:0071493) |
1.8 | 94.2 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
1.8 | 8.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.8 | 5.3 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
1.7 | 12.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.7 | 8.6 | GO:0021559 | trigeminal nerve development(GO:0021559) |
1.7 | 3.4 | GO:0021914 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.7 | 1.7 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
1.7 | 1.7 | GO:0003186 | tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
1.7 | 5.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.7 | 1.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
1.7 | 8.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.7 | 3.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
1.7 | 5.0 | GO:0015744 | succinate transport(GO:0015744) |
1.7 | 5.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.6 | 6.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.6 | 4.9 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
1.6 | 4.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.6 | 1.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.6 | 3.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
1.6 | 3.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
1.6 | 1.6 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
1.6 | 4.8 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.6 | 4.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
1.6 | 4.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.6 | 1.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
1.6 | 1.6 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
1.5 | 7.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
1.5 | 7.7 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.5 | 7.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
1.5 | 10.7 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.5 | 3.0 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.5 | 4.5 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.5 | 3.0 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
1.5 | 1.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.5 | 8.9 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
1.5 | 1.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.5 | 8.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.5 | 4.4 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
1.5 | 4.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
1.4 | 8.6 | GO:0035878 | nail development(GO:0035878) |
1.4 | 8.6 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.4 | 1.4 | GO:0046864 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.4 | 2.8 | GO:0090427 | activation of meiosis(GO:0090427) |
1.4 | 1.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
1.4 | 1.4 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.4 | 1.4 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
1.4 | 4.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
1.4 | 4.2 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
1.4 | 5.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.4 | 4.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.4 | 4.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.4 | 4.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
1.4 | 5.5 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
1.4 | 2.7 | GO:0033058 | directional locomotion(GO:0033058) |
1.4 | 4.1 | GO:0001555 | oocyte growth(GO:0001555) |
1.4 | 1.4 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
1.3 | 13.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
1.3 | 4.0 | GO:0071313 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.3 | 5.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.3 | 5.3 | GO:2000822 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
1.3 | 4.0 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.3 | 14.6 | GO:0022038 | corpus callosum development(GO:0022038) |
1.3 | 5.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.3 | 7.8 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
1.3 | 1.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.3 | 3.9 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.3 | 3.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.3 | 2.6 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.3 | 5.2 | GO:0060290 | transdifferentiation(GO:0060290) |
1.3 | 6.4 | GO:0060068 | vagina development(GO:0060068) |
1.3 | 2.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.3 | 1.3 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
1.3 | 2.5 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
1.3 | 1.3 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.3 | 1.3 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
1.2 | 3.7 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
1.2 | 3.7 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
1.2 | 1.2 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
1.2 | 1.2 | GO:0003192 | mitral valve formation(GO:0003192) |
1.2 | 16.9 | GO:0001709 | cell fate determination(GO:0001709) |
1.2 | 2.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.2 | 8.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.2 | 1.2 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.2 | 1.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.2 | 2.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.2 | 7.2 | GO:0048665 | neuron fate specification(GO:0048665) |
1.2 | 4.8 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
1.2 | 1.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.2 | 3.6 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.2 | 1.2 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
1.2 | 3.5 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
1.2 | 1.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) cellular response to cocaine(GO:0071314) |
1.2 | 2.3 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
1.1 | 13.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
1.1 | 3.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.1 | 8.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.1 | 1.1 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
1.1 | 13.5 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
1.1 | 6.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.1 | 12.3 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
1.1 | 1.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
1.1 | 5.5 | GO:0021854 | hypothalamus development(GO:0021854) |
1.1 | 3.3 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.1 | 2.2 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.1 | 2.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.1 | 3.2 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.1 | 2.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
1.1 | 2.1 | GO:0061743 | motor learning(GO:0061743) |
1.1 | 5.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.1 | 7.4 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
1.1 | 5.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
1.0 | 2.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.0 | 2.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.0 | 2.1 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.0 | 3.1 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
1.0 | 3.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
1.0 | 3.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
1.0 | 1.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
1.0 | 2.0 | GO:0060914 | heart formation(GO:0060914) |
1.0 | 6.1 | GO:0015671 | oxygen transport(GO:0015671) |
1.0 | 7.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.0 | 3.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.0 | 3.0 | GO:0009629 | response to gravity(GO:0009629) |
1.0 | 5.0 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
1.0 | 2.0 | GO:0061323 | cell proliferation involved in heart morphogenesis(GO:0061323) positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
1.0 | 5.0 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.0 | 5.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
1.0 | 3.0 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
1.0 | 3.9 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
1.0 | 2.0 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
1.0 | 1.9 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.0 | 1.0 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
1.0 | 1.0 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.0 | 3.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
1.0 | 2.9 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
1.0 | 2.9 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
1.0 | 2.9 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.0 | 1.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.0 | 5.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.0 | 1.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.0 | 2.9 | GO:0060037 | pharyngeal system development(GO:0060037) |
1.0 | 2.9 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.9 | 3.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.9 | 6.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.9 | 0.9 | GO:0051938 | L-glutamate import(GO:0051938) |
0.9 | 0.9 | GO:0061525 | hindgut development(GO:0061525) |
0.9 | 3.7 | GO:0030578 | PML body organization(GO:0030578) |
0.9 | 9.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.9 | 4.7 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.9 | 0.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.9 | 9.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.9 | 2.8 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.9 | 0.9 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.9 | 2.8 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.9 | 15.6 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.9 | 2.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.9 | 2.8 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.9 | 8.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.9 | 2.7 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.9 | 2.7 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.9 | 4.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.9 | 0.9 | GO:0061047 | positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.9 | 3.6 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.9 | 1.8 | GO:0030421 | defecation(GO:0030421) |
0.9 | 4.5 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.9 | 0.9 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.9 | 3.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.9 | 0.9 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.9 | 0.9 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.9 | 8.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.9 | 0.9 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.9 | 2.6 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.9 | 1.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.9 | 3.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.9 | 1.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.9 | 2.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.9 | 1.7 | GO:0030903 | notochord development(GO:0030903) |
0.9 | 2.6 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.9 | 1.7 | GO:0021794 | thalamus development(GO:0021794) |
0.9 | 0.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.9 | 6.0 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.9 | 3.4 | GO:0010288 | response to lead ion(GO:0010288) |
0.9 | 2.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.9 | 0.9 | GO:0072193 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.8 | 3.4 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.8 | 2.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.8 | 4.2 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.8 | 0.8 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.8 | 1.7 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.8 | 5.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.8 | 3.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.8 | 3.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 4.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 1.7 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.8 | 15.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.8 | 3.3 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.8 | 2.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.8 | 0.8 | GO:0007512 | adult heart development(GO:0007512) |
0.8 | 3.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 2.5 | GO:1903232 | melanosome assembly(GO:1903232) |
0.8 | 0.8 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.8 | 0.8 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.8 | 2.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.8 | 2.4 | GO:0060023 | soft palate development(GO:0060023) |
0.8 | 1.6 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.8 | 2.4 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.8 | 5.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.8 | 4.0 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.8 | 4.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 0.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.8 | 2.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 4.0 | GO:0031033 | myosin filament organization(GO:0031033) |
0.8 | 0.8 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.8 | 2.4 | GO:0033504 | floor plate development(GO:0033504) |
0.8 | 3.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.8 | 3.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.8 | 0.8 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.8 | 0.8 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
0.8 | 3.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.8 | 3.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.8 | 0.8 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.8 | 22.4 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.8 | 0.8 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.8 | 2.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.8 | 6.1 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.8 | 0.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.8 | 3.8 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.8 | 5.3 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.8 | 2.3 | GO:0007379 | segment specification(GO:0007379) |
0.8 | 1.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.8 | 1.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.8 | 0.8 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.7 | 3.0 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.7 | 2.2 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.7 | 9.7 | GO:0060021 | palate development(GO:0060021) |
0.7 | 1.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.7 | 3.7 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.7 | 1.5 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.7 | 1.5 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.7 | 0.7 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.7 | 8.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.7 | 3.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.7 | 8.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.7 | 13.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.7 | 2.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.7 | 2.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.7 | 1.4 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.7 | 0.7 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.7 | 1.4 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.7 | 0.7 | GO:0003171 | atrioventricular valve development(GO:0003171) |
0.7 | 1.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.7 | 0.7 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.7 | 2.8 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.7 | 2.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.7 | 2.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 0.7 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.7 | 3.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.7 | 0.7 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.7 | 1.4 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.7 | 7.0 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.7 | 4.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.7 | 1.4 | GO:0032202 | telomere assembly(GO:0032202) |
0.7 | 2.1 | GO:0097503 | sialylation(GO:0097503) |
0.7 | 0.7 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.7 | 2.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.7 | 1.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.7 | 0.7 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.7 | 1.4 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
0.7 | 0.7 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.7 | 0.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.7 | 4.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.7 | 2.7 | GO:0090399 | replicative senescence(GO:0090399) |
0.7 | 2.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.7 | 2.7 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.7 | 0.7 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.7 | 2.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.7 | 2.7 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 8.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.7 | 2.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 2.0 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.7 | 1.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.7 | 3.3 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.7 | 1.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.6 | 4.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.6 | 3.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 1.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.6 | 1.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 1.9 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 0.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.6 | 3.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 3.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.6 | 3.2 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.6 | 5.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.6 | 3.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.6 | 1.9 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.6 | 0.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.6 | 1.9 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.6 | 3.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.6 | 3.1 | GO:0033574 | response to testosterone(GO:0033574) |
0.6 | 3.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.6 | 4.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.6 | 3.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.6 | 1.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.6 | 1.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.6 | 1.8 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.6 | 1.8 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.6 | 1.2 | GO:0006868 | glutamine transport(GO:0006868) |
0.6 | 3.0 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.6 | 1.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.6 | 4.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.6 | 3.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.6 | 2.4 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.6 | 1.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.6 | 1.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.6 | 0.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.6 | 1.8 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.6 | 2.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 7.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.6 | 1.8 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.6 | 1.8 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.6 | 2.4 | GO:0003161 | cardiac conduction system development(GO:0003161) |
0.6 | 3.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.6 | 1.8 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.6 | 6.5 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.6 | 0.6 | GO:0060022 | hard palate development(GO:0060022) |
0.6 | 2.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.6 | 1.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.6 | 1.2 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.6 | 1.8 | GO:0015755 | fructose transport(GO:0015755) |
0.6 | 2.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.6 | 0.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.6 | 1.7 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.6 | 1.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.6 | 1.7 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.6 | 1.7 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.6 | 4.1 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
0.6 | 1.2 | GO:0003383 | apical constriction(GO:0003383) |
0.6 | 2.9 | GO:0010171 | body morphogenesis(GO:0010171) |
0.6 | 9.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.6 | 3.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 3.4 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.6 | 1.1 | GO:0060947 | cardiac vascular smooth muscle cell differentiation(GO:0060947) |
0.6 | 1.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.6 | 10.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.6 | 6.7 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.6 | 12.9 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.6 | 1.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 1.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.6 | 1.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.6 | 1.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 0.5 | GO:0060071 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) |
0.5 | 0.5 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 2.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.5 | 2.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.5 | 1.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.5 | 1.1 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.5 | 0.5 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.5 | 1.6 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.5 | 1.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.5 | 1.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 1.6 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.5 | 4.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 2.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 2.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.5 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 2.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.5 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 3.7 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.5 | 0.5 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.5 | 0.5 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.5 | 1.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.5 | 1.6 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.5 | 3.7 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.5 | 4.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.5 | 1.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 1.6 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.5 | 2.6 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.5 | 0.5 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.5 | 1.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.5 | 0.5 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.5 | 0.5 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.5 | 1.0 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.5 | 1.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.5 | 1.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.5 | 3.5 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.5 | 2.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 3.5 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.5 | 3.0 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.5 | 3.5 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.5 | 1.0 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.5 | 4.5 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.5 | 0.5 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.5 | 3.0 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.5 | 2.0 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 1.5 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.5 | 3.9 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.5 | 1.5 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.5 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.5 | 15.9 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.5 | 1.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.5 | 4.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.5 | 5.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.5 | 3.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 1.4 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.5 | 1.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.5 | 1.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 0.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.5 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.5 | 0.9 | GO:0034443 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) |
0.5 | 1.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 1.4 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.5 | 0.9 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.5 | 1.4 | GO:0015747 | urate transport(GO:0015747) |
0.5 | 2.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.5 | 0.5 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.5 | 2.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 1.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.5 | 0.9 | GO:0046909 | intermembrane transport(GO:0046909) |
0.5 | 4.5 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.4 | 0.9 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.4 | 2.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 0.9 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.4 | 0.9 | GO:0014020 | primary neural tube formation(GO:0014020) |
0.4 | 2.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.4 | 1.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) nucleotide transmembrane transport(GO:1901679) |
0.4 | 0.4 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.4 | 3.1 | GO:0070417 | cellular response to cold(GO:0070417) |
0.4 | 0.4 | GO:0060323 | head morphogenesis(GO:0060323) |
0.4 | 0.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.4 | 2.2 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 2.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.4 | 1.3 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 4.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.4 | 0.4 | GO:0034137 | positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
0.4 | 3.0 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.4 | 0.4 | GO:0042320 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.4 | 1.7 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.4 | 23.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.4 | 0.9 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.4 | 0.4 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.4 | 0.9 | GO:0036475 | neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced neuron death(GO:1903203) |
0.4 | 1.7 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.4 | 1.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 0.9 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.4 | 4.3 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.4 | 2.1 | GO:0034698 | response to gonadotropin(GO:0034698) |
0.4 | 0.9 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.4 | 1.3 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.4 | 1.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.4 | 0.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 2.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.4 | 1.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.4 | 0.8 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.4 | 0.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.4 | 3.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.4 | 1.7 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.4 | 0.4 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 0.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.4 | 0.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.4 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.4 | 1.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 0.4 | GO:1902965 | protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.4 | 1.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 0.4 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.4 | 0.4 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.4 | 0.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.4 | 1.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 1.2 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.4 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 1.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.4 | 1.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 3.9 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 1.2 | GO:0042637 | catagen(GO:0042637) |
0.4 | 2.4 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.4 | 0.8 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.4 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.4 | 0.8 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.4 | 0.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 0.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 0.4 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.4 | 0.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.4 | 1.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 0.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 0.4 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.4 | 2.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.4 | 0.4 | GO:1902669 | positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
0.4 | 12.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.4 | 1.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.4 | 1.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 5.6 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.4 | 1.1 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.4 | 0.7 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 2.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.4 | 0.4 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.4 | 1.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.4 | 4.0 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.4 | 3.6 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.4 | 1.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 1.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.4 | 0.4 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.4 | 1.8 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.4 | 1.1 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 1.4 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.4 | 2.1 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.4 | 0.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 1.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.4 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 1.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 7.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.4 | 1.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 4.6 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.3 | 4.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.3 | 0.3 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.3 | 0.3 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.3 | 0.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 0.3 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.3 | 0.7 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.3 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 1.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.3 | 1.0 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.3 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 0.7 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.3 | 4.3 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
0.3 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 1.0 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 1.7 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.3 | 1.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.3 | 1.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.3 | 1.0 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 1.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 2.0 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 2.3 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.3 | 6.2 | GO:0030239 | myofibril assembly(GO:0030239) |
0.3 | 1.0 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
0.3 | 3.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 2.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.3 | 1.3 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.3 | 0.6 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 1.6 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.3 | 0.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.3 | 0.6 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.3 | 0.9 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.3 | 1.9 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.3 | 0.3 | GO:0052200 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.3 | 2.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 7.5 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 0.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.3 | 1.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.3 | 5.2 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.3 | 0.9 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.3 | 1.2 | GO:0031000 | response to caffeine(GO:0031000) |
0.3 | 0.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 1.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 0.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 0.3 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.3 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.3 | 4.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.3 | 2.4 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.3 | 1.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 0.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 2.9 | GO:0015695 | organic cation transport(GO:0015695) |
0.3 | 1.4 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 1.4 | GO:0030901 | midbrain development(GO:0030901) |
0.3 | 6.3 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.3 | 0.6 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.3 | 0.6 | GO:0090102 | cochlea development(GO:0090102) |
0.3 | 1.1 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 0.3 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.3 | 0.3 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.3 | 0.6 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.3 | 1.9 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
0.3 | 0.6 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.3 | 0.3 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 1.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.8 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.3 | 0.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.3 | 1.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 0.8 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.3 | 2.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 6.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 0.5 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 3.7 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.3 | 0.3 | GO:0044849 | estrous cycle(GO:0044849) |
0.3 | 1.9 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.3 | 0.8 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.3 | 0.3 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 0.3 | GO:1900245 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 0.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.3 | 1.0 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.3 | 1.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.3 | 6.7 | GO:0007140 | male meiosis(GO:0007140) |
0.3 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 0.5 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 0.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.3 | 1.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.3 | 0.5 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.2 | 0.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.2 | 1.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.5 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 1.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.2 | 1.2 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 0.5 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.7 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.2 | 2.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.2 | 0.7 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.2 | 0.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 1.5 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
0.2 | 0.5 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.2 | 0.2 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.2 | 0.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 2.8 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.2 | 0.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.2 | 0.5 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
0.2 | 0.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 0.2 | GO:0019230 | proprioception(GO:0019230) |
0.2 | 0.5 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 6.3 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.2 | 2.3 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.2 | 0.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 1.4 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.2 | 3.2 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.2 | 0.9 | GO:0098764 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.2 | 0.5 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.2 | 0.2 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.5 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.2 | 0.5 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.2 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 5.6 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 1.6 | GO:0044253 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.2 | 0.9 | GO:0070589 | cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) |
0.2 | 0.7 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.2 | 0.7 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 0.2 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.2 | 2.2 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.2 | 0.2 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.2 | 0.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.2 | 0.7 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.2 | 1.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.2 | 1.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.2 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 0.8 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.8 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.2 | 0.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.4 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.8 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 0.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.2 | 4.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.2 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 1.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 0.4 | GO:0051182 | coenzyme transport(GO:0051182) |
0.2 | 0.8 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 1.5 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.9 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.2 | 0.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.2 | 0.8 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 0.6 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 2.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.2 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.2 | 0.2 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.2 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 1.5 | GO:0036303 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.2 | 0.2 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.2 | 0.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.5 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.5 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.2 | 1.3 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 1.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 0.4 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.5 | GO:0001927 | exocyst assembly(GO:0001927) |
0.2 | 4.5 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.7 | GO:0043137 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.2 | 2.4 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.2 | 0.3 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 1.4 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 0.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.3 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 0.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.2 | 0.2 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 3.0 | GO:0055006 | cardiac cell development(GO:0055006) |
0.2 | 2.3 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.2 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 0.5 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.2 | 0.2 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.2 | 1.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.2 | 0.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 1.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 0.9 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 2.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 0.3 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.2 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.6 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.1 | 0.1 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.1 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.1 | 0.4 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 1.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 3.7 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.1 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 1.4 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.1 | 0.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.3 | GO:0071727 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 0.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.1 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.1 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.6 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.5 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.5 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.1 | 2.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.1 | 0.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.1 | 0.1 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.1 | 0.7 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 0.1 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.7 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 1.4 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
0.1 | 0.5 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0003096 | renal sodium ion transport(GO:0003096) |
0.1 | 0.1 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.1 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.6 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.3 | GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
0.1 | 0.1 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 1.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.1 | 1.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.4 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.1 | 0.9 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.4 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.6 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.1 | 0.7 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 1.1 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.5 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.6 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 1.2 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.1 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 | 1.4 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.5 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 0.1 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.6 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 1.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 1.3 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 1.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.1 | 0.1 | GO:0003283 | atrial septum development(GO:0003283) |
0.1 | 2.4 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 0.2 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
0.1 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.3 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.1 | 0.5 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 1.0 | GO:0048240 | sperm capacitation(GO:0048240) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.7 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.4 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.1 | 0.1 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
0.1 | 0.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.1 | 0.3 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.1 | GO:0006113 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.1 | 0.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.2 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.7 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.1 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.1 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 3.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 2.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.1 | 0.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 1.8 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.1 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.1 | 0.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 1.1 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.1 | 0.1 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.1 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.6 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.3 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.0 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.0 | 0.7 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.0 | 0.8 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.0 | 3.3 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 1.1 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.5 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.0 | 3.8 | GO:0007286 | spermatid development(GO:0007286) |
0.0 | 0.1 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.0 | 0.1 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.2 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 0.1 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.1 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.1 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.1 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.8 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.0 | 0.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.0 | 0.2 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.0 | 0.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.0 | 0.1 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.0 | 0.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.0 | 0.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.0 | 0.0 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.0 | 1.2 | GO:0019236 | response to pheromone(GO:0019236) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 16.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
3.0 | 9.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.7 | 2.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.7 | 31.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
2.0 | 2.0 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
2.0 | 15.8 | GO:0005861 | troponin complex(GO:0005861) |
1.9 | 7.4 | GO:0071953 | elastic fiber(GO:0071953) |
1.9 | 16.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.8 | 3.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.8 | 10.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.8 | 7.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.7 | 1.7 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.7 | 5.0 | GO:1990393 | 3M complex(GO:1990393) |
1.6 | 19.5 | GO:0043194 | axon initial segment(GO:0043194) |
1.6 | 6.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.6 | 6.2 | GO:1990745 | EARP complex(GO:1990745) |
1.5 | 12.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.5 | 5.8 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.4 | 6.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.3 | 1.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.3 | 4.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.3 | 3.8 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.2 | 3.7 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.2 | 10.0 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.2 | 4.9 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.2 | 3.7 | GO:0044393 | microspike(GO:0044393) |
1.2 | 7.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.2 | 16.7 | GO:0043196 | varicosity(GO:0043196) |
1.2 | 3.6 | GO:0048179 | activin receptor complex(GO:0048179) |
1.2 | 3.5 | GO:0061574 | ASAP complex(GO:0061574) |
1.2 | 7.0 | GO:0005915 | zonula adherens(GO:0005915) |
1.2 | 4.6 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.1 | 8.9 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.1 | 7.8 | GO:0032584 | growth cone membrane(GO:0032584) |
1.1 | 3.2 | GO:0000322 | storage vacuole(GO:0000322) |
1.1 | 3.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.0 | 4.1 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.0 | 343.3 | GO:0005667 | transcription factor complex(GO:0005667) |
1.0 | 7.9 | GO:0045179 | apical cortex(GO:0045179) |
1.0 | 4.9 | GO:0099738 | cell cortex region(GO:0099738) |
1.0 | 10.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.9 | 3.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.9 | 2.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 2.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.9 | 10.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.9 | 10.8 | GO:0005916 | fascia adherens(GO:0005916) |
0.9 | 7.0 | GO:0036157 | outer dynein arm(GO:0036157) |
0.9 | 2.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.8 | 3.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 13.3 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.8 | 0.8 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.8 | 1.6 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 4.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.8 | 4.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.8 | 9.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.8 | 2.4 | GO:0000811 | GINS complex(GO:0000811) |
0.8 | 14.3 | GO:0043034 | costamere(GO:0043034) |
0.8 | 2.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.8 | 3.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 8.1 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.7 | 66.5 | GO:0031674 | I band(GO:0031674) |
0.7 | 2.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 4.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.7 | 1.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.7 | 6.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 2.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.7 | 7.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.6 | 3.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.6 | 17.8 | GO:0016235 | aggresome(GO:0016235) |
0.6 | 3.2 | GO:0031430 | M band(GO:0031430) |
0.6 | 10.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.6 | 1.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 3.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.6 | 1.8 | GO:0055087 | Ski complex(GO:0055087) |
0.6 | 3.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.6 | 5.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.6 | 11.2 | GO:0005922 | connexon complex(GO:0005922) |
0.6 | 2.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.6 | 1.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.6 | 3.3 | GO:0031672 | A band(GO:0031672) |
0.6 | 3.3 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.6 | 2.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.6 | 2.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 10.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.5 | 1.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.5 | 5.8 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.5 | 1.6 | GO:0035061 | interchromatin granule(GO:0035061) |
0.5 | 5.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.5 | 6.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 2.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.5 | 1.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 6.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.5 | 0.5 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 2.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 18.0 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.5 | 2.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 5.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.5 | 2.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.5 | 5.0 | GO:0001527 | microfibril(GO:0001527) |
0.5 | 4.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.5 | 2.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.5 | 1.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.5 | 4.6 | GO:0005921 | gap junction(GO:0005921) |
0.5 | 4.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 5.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.4 | 3.1 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.4 | 1.8 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.7 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 3.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.4 | 14.7 | GO:0005844 | polysome(GO:0005844) |
0.4 | 2.5 | GO:0098645 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.4 | 8.8 | GO:0051233 | spindle midzone(GO:0051233) |
0.4 | 1.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.4 | 4.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.4 | 3.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 6.7 | GO:0001741 | XY body(GO:0001741) |
0.4 | 3.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 1.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 3.4 | GO:0060091 | kinocilium(GO:0060091) |
0.4 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.4 | 3.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.4 | 8.3 | GO:0030016 | myofibril(GO:0030016) |
0.4 | 2.5 | GO:0005688 | U6 snRNP(GO:0005688) |
0.3 | 1.0 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 2.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.0 | GO:0043293 | apoptosome(GO:0043293) |
0.3 | 1.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 0.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 12.9 | GO:0045095 | keratin filament(GO:0045095) |
0.3 | 6.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.3 | 1.3 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 1.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 1.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 4.8 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 1.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 1.5 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 2.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.3 | 1.5 | GO:0005827 | polar microtubule(GO:0005827) |
0.3 | 10.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 4.1 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.3 | 1.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 1.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 1.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.3 | 4.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.7 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 2.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 1.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 5.8 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 1.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 10.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 1.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.3 | 12.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 1.0 | GO:0002177 | manchette(GO:0002177) |
0.3 | 4.0 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 2.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.2 | 4.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.4 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 1.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.2 | 12.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 8.6 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 1.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.2 | 0.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 2.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 2.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.2 | 1.5 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 8.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 1.5 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.3 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 3.9 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.9 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 1.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 1.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 0.8 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 3.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.2 | 1.2 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.2 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.2 | 0.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.0 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.2 | 1.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 2.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 3.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.2 | 3.0 | GO:0044295 | axonal growth cone(GO:0044295) |
0.2 | 49.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.2 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.2 | 1.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 16.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 2.5 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 2.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 1.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.8 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.3 | GO:0000243 | commitment complex(GO:0000243) |
0.2 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 0.5 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.1 | 1.6 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.3 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 2.9 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.1 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.6 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.4 | GO:0097441 | basilar dendrite(GO:0097441) |
0.1 | 2.9 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.2 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 2.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 2.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.3 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 1.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.6 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.1 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 3.2 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 7.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.7 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.1 | 0.3 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.7 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 1.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 1.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.1 | 0.6 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 3.8 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 7.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.4 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 4.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 4.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 1.6 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 1.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 1.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.0 | 0.0 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 0.1 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.0 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
4.1 | 12.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
3.8 | 26.7 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
3.1 | 18.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.9 | 8.6 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.8 | 24.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
2.6 | 10.4 | GO:0031433 | telethonin binding(GO:0031433) |
2.6 | 13.0 | GO:0003680 | AT DNA binding(GO:0003680) |
2.5 | 7.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
2.5 | 57.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
2.5 | 10.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.4 | 21.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.3 | 2.3 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.3 | 27.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
2.2 | 13.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.2 | 6.5 | GO:0051373 | FATZ binding(GO:0051373) |
2.1 | 24.7 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
2.0 | 6.1 | GO:0030172 | troponin C binding(GO:0030172) |
2.0 | 7.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.0 | 5.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.8 | 5.4 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.7 | 8.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.7 | 5.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
1.7 | 9.9 | GO:0048495 | Roundabout binding(GO:0048495) |
1.6 | 4.8 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.6 | 3.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.5 | 3.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.5 | 4.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.5 | 7.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.5 | 4.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.5 | 4.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
1.5 | 4.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.5 | 4.5 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.5 | 11.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.5 | 4.4 | GO:0031014 | troponin T binding(GO:0031014) |
1.5 | 10.2 | GO:0031432 | titin binding(GO:0031432) |
1.4 | 7.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.4 | 4.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 5.5 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.4 | 8.1 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.3 | 1.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
1.3 | 40.5 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
1.3 | 10.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.3 | 15.3 | GO:0035198 | miRNA binding(GO:0035198) |
1.3 | 8.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.3 | 10.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.2 | 3.7 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.2 | 36.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
1.2 | 20.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
1.2 | 2.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
1.2 | 3.6 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.2 | 10.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.2 | 4.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.2 | 2.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.2 | 3.5 | GO:0034934 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
1.1 | 2.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.1 | 3.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.1 | 3.4 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.1 | 5.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.1 | 4.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.1 | 2.3 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
1.1 | 4.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.1 | 5.6 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.1 | 14.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.1 | 4.4 | GO:0030957 | Tat protein binding(GO:0030957) |
1.1 | 2.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.1 | 3.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.1 | 3.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.1 | 3.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.1 | 7.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.1 | 3.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.1 | 2.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.0 | 5.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.0 | 3.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
1.0 | 6.1 | GO:0005344 | oxygen transporter activity(GO:0005344) |
1.0 | 3.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.0 | 14.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
1.0 | 4.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.0 | 3.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.0 | 2.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 3.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
1.0 | 2.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.0 | 4.0 | GO:0004966 | galanin receptor activity(GO:0004966) |
1.0 | 10.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.0 | 3.9 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
1.0 | 1.0 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.0 | 2.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.0 | 3.9 | GO:1990254 | keratin filament binding(GO:1990254) |
1.0 | 2.9 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.0 | 2.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.9 | 4.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.9 | 7.5 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.9 | 3.8 | GO:0070888 | E-box binding(GO:0070888) |
0.9 | 16.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.9 | 12.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.9 | 10.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.9 | 5.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.9 | 0.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.9 | 2.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.9 | 2.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.9 | 2.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.9 | 6.2 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.9 | 1.8 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.9 | 2.6 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.9 | 182.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.9 | 1.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.9 | 5.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.8 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.8 | 4.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.8 | 3.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.8 | 0.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.8 | 1.7 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.8 | 6.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.8 | 117.4 | GO:0000987 | core promoter proximal region sequence-specific DNA binding(GO:0000987) |
0.8 | 1.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.8 | 3.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 2.5 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.8 | 8.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.8 | 1.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.8 | 2.4 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.8 | 6.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.8 | 6.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.8 | 3.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.8 | 3.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 7.1 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.8 | 2.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.8 | 0.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.8 | 5.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.8 | 3.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.8 | 394.1 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.8 | 2.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 3.9 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 1.6 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.8 | 3.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 24.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.8 | 3.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 0.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.8 | 2.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.7 | 3.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.7 | 3.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.7 | 2.2 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.7 | 2.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.7 | 9.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.7 | 3.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 2.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.7 | 4.3 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.7 | 5.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.7 | 3.5 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.7 | 2.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.7 | 4.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.7 | 6.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.7 | 2.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.7 | 2.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 14.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 15.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.7 | 2.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 3.3 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.7 | 2.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.7 | 0.7 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.7 | 0.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.6 | 5.1 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.6 | 15.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.6 | 1.3 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 1.9 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.6 | 2.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 7.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 10.6 | GO:0043274 | phospholipase binding(GO:0043274) |
0.6 | 9.3 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.6 | 2.5 | GO:0005534 | galactose binding(GO:0005534) |
0.6 | 1.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.6 | 0.6 | GO:0005119 | smoothened binding(GO:0005119) |
0.6 | 1.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.6 | 4.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.6 | 3.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.6 | 2.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.6 | 2.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.6 | 1.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 2.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.6 | 1.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.6 | 2.3 | GO:0045340 | mercury ion binding(GO:0045340) |
0.6 | 1.7 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.6 | 2.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.6 | 5.1 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.6 | 2.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 3.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.6 | 1.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.6 | 3.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 10.4 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.5 | 11.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 2.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.5 | 1.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.5 | 1.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 2.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.5 | 1.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.5 | 11.3 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.5 | 1.5 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 5.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.5 | 2.0 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 0.5 | GO:0034618 | arginine binding(GO:0034618) |
0.5 | 0.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 7.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.5 | 1.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.5 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.5 | 1.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.5 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 1.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 0.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.5 | 1.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 4.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.5 | 0.5 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.5 | 2.8 | GO:0033265 | choline binding(GO:0033265) |
0.5 | 1.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.5 | 0.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.5 | 2.3 | GO:0046790 | virion binding(GO:0046790) |
0.5 | 1.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.5 | 0.9 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.5 | 7.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.4 | 8.1 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.4 | 3.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 1.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.4 | 7.2 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 3.1 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 1.8 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.4 | 2.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.4 | 15.4 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.4 | 6.2 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.4 | 3.5 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.4 | 3.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.4 | 0.9 | GO:0019002 | GMP binding(GO:0019002) |
0.4 | 2.1 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.4 | 4.6 | GO:0031005 | filamin binding(GO:0031005) |
0.4 | 1.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.4 | 1.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.4 | 1.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.4 | 0.8 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 1.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.4 | 1.6 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 1.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 0.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.4 | 2.0 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 1.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.4 | 0.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 4.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 2.0 | GO:0036122 | BMP binding(GO:0036122) |
0.4 | 4.8 | GO:0070402 | NADPH binding(GO:0070402) |
0.4 | 0.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.4 | 2.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.4 | 2.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 13.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.4 | 0.4 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.4 | 3.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.4 | 3.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.4 | 2.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 1.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.4 | 2.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.4 | 0.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 2.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 3.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.4 | 1.1 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.4 | 1.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 1.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 2.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.4 | 6.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 1.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.4 | 1.8 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.4 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 1.8 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.3 | 1.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.3 | 1.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 31.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.3 | 4.7 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 2.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 1.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.3 | 1.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 1.0 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 2.3 | GO:0034534 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.3 | 1.0 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 1.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.3 | 2.9 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 1.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.3 | 1.0 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.3 | 0.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.3 | 6.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 3.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.3 | 0.9 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.6 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.3 | 2.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 4.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.3 | 1.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 1.5 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 1.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.3 | 1.8 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.3 | 2.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 7.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.3 | 0.9 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 0.3 | GO:0015927 | trehalase activity(GO:0015927) |
0.3 | 1.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 0.6 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 0.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 1.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.3 | 0.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 7.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 4.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 0.5 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 1.0 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.3 | 0.5 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.3 | 1.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 21.0 | GO:0005179 | hormone activity(GO:0005179) |
0.3 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
0.3 | 1.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.2 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.2 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.2 | 0.7 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.2 | 1.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 4.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 2.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 0.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.2 | 1.8 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.5 | GO:0034838 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.2 | 2.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.4 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.7 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.3 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.4 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 8.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 1.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.2 | 0.6 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.2 | 1.9 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 1.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.2 | 0.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.4 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.8 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 3.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.2 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.2 | 2.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.2 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.2 | 1.4 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.2 | 0.6 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.4 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 0.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.5 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.4 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.2 | GO:0043398 | HLH domain binding(GO:0043398) |
0.2 | 0.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 5.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.2 | 1.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.7 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.3 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 1.5 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 0.3 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 2.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.2 | 0.3 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
0.2 | 1.4 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 3.7 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 1.9 | GO:0008143 | poly(A) binding(GO:0008143) |
0.2 | 0.2 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
0.1 | 0.1 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 14.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.1 | 3.0 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 3.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 2.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 1.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.3 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.8 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 2.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 0.2 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.2 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 2.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 3.7 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 2.0 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 1.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.1 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 1.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.4 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.6 | GO:0030546 | receptor activator activity(GO:0030546) |
0.1 | 0.3 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.1 | 0.4 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.1 | 2.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 0.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 1.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.5 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 1.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 0.7 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 1.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 1.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.8 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.2 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.6 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 1.3 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.2 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.1 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.9 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 2.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 5.4 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 3.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.1 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 5.9 | GO:0003729 | mRNA binding(GO:0003729) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.9 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.1 | 0.2 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.1 | 10.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.1 | 0.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 2.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.0 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0071253 | connexin binding(GO:0071253) |
0.0 | 0.3 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.1 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 2.8 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 1.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.0 | GO:0055100 | adiponectin binding(GO:0055100) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.0 | 6.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 1.3 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.0 | 0.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 1.0 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 1.4 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 5.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 2.5 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.9 | 54.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.7 | 5.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
1.6 | 1.6 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.3 | 14.3 | PID ALK2 PATHWAY | ALK2 signaling events |
1.2 | 4.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.2 | 50.6 | NABA COLLAGENS | Genes encoding collagen proteins |
1.1 | 1.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 12.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.9 | 16.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 15.2 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.8 | 27.7 | PID BMP PATHWAY | BMP receptor signaling |
0.8 | 25.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.8 | 6.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.8 | 18.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 3.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.7 | 2.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.7 | 15.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.6 | 36.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.6 | 4.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 12.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 4.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.5 | 3.6 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.5 | 80.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 1.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 5.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 18.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.5 | 9.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.4 | 7.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 10.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.4 | 2.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 3.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 2.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.4 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 13.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.4 | 1.8 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.4 | 12.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.3 | 3.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 1.0 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 4.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.3 | 4.6 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 3.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 0.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 13.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 2.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 8.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.3 | 2.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.3 | 4.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.3 | 3.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 5.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 0.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 3.4 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 4.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 0.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.2 | 3.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 4.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 4.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 5.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 0.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 3.2 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.6 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 0.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 22.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 0.9 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 2.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 8.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 7.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
1.8 | 1.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.7 | 22.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.6 | 1.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.5 | 40.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.4 | 30.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.3 | 18.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.3 | 67.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.2 | 12.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.2 | 26.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.1 | 38.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.8 | 23.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.8 | 5.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.8 | 63.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.8 | 12.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.7 | 0.7 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.7 | 15.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.7 | 7.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.7 | 5.6 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.7 | 2.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 13.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 7.8 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.6 | 5.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 3.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.6 | 13.3 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.6 | 7.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.6 | 6.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.5 | 6.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.5 | 2.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 3.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.5 | 3.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.5 | 4.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 3.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.5 | 5.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.5 | 1.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.5 | 14.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 9.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.5 | 0.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.5 | 9.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.5 | 3.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.4 | 2.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 6.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 6.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 1.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.4 | 1.7 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.4 | 3.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.4 | 4.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 31.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.4 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 4.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 7.7 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 3.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 7.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.3 | 13.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 4.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 12.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.3 | 8.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.3 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.3 | 6.0 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.3 | 7.4 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.3 | 1.7 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.3 | 4.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 0.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.3 | 1.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.3 | 2.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 0.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 1.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.3 | 2.0 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 3.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.2 | 2.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 8.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 2.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 1.8 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.2 | 3.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 0.9 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.2 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 0.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 1.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 0.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 14.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.2 | 1.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 5.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 22.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 6.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.9 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 2.0 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.7 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.5 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.6 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 0.3 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.1 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 0.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.8 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.0 | 0.0 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.0 | 1.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.4 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 0.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.1 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.0 | 0.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |